CELLULOSEMIKROFIBRILLEN

European patent · EP3145958 · In force

Register entry

Publication number
EP3145958
Application number
EP15725102
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 21, 2015
Published
Mar 29, 2017
Granted
Jan 24, 2024
Protection ends at the latest
May 20, 2035
Next annual fee due
May 31, 2027
IPC classes
C08B 15/00 (2006.01)
C12P 19/00 (2006.01)
C08L 1/02 (2006.01)
C08L 5/00 (2006.01)
D21H 11/20 (2006.01)
Priority
GB 201409047 21.05.2014
PCT application
PCT/GB2015/051486 21.05.2015
PCT publication
WO2015/177548 26.11.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 18, 2026

    Change

    Published in Swissreg on 18.06.2026

  2. Jun 25, 2025

    Change

    Published in Swissreg on 25.06.2025

  3. Dec 4, 2024

    Change

    Published in Swissreg on 04.12.2024

  4. Jun 12, 2024

    Change

    Published in Swissreg on 12.06.2024

  5. Jan 24, 2024

    Granted

    Published in Swissreg on 24.01.2024

Parties

Holder

University of Copenhagen

Postbox 2177 Norregade 10, 1017 Copenhagen K, DK

Cellucomp Limited

Unit 3, West Dock Harbour Place Burntisland, Fife KY3 9DW, GB

Novozymes A/S

Krogshoejvej 36, 2880 Bagsvaerd, DK

Inventor

JØRGENSEN, Bodil

DK-3500 Værløse, DK

WHALE, Eric

Fife KY3 9DW, GB

LUND, Henrik

DK-3500 Vaerloese, DK

KALUM, Lisbeth

DK-3500 Vaerloese, DK

CASSLAND, Bjoern Lennart Pierre Alexander

S-235 37 Vellinge, SE

HEPWORTH, David

Fife KY3 9DW, GB

ULVSKOV, Peter

DK-2920 Charlottenlund, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.